Mani Foroohar

Stock Analyst at Leerink Partners

(2.22)
# 2,719
Out of 4,896 analysts
164
Total ratings
48.31%
Success rate
n/a
Average return

Stocks Rated by Mani Foroohar

Rocket Pharmaceuticals
May 28, 2025
Downgrades: Market Perform
Price Target: $37$8
Current: $2.96
Upside: +170.27%
Lexeo Therapeutics
Mar 24, 2025
Maintains: Outperform
Price Target: $19$18
Current: $4.47
Upside: +302.68%
Recursion Pharmaceuticals
Feb 28, 2025
Maintains: Market Perform
Price Target: $7$6
Current: $5.28
Upside: +13.64%
4D Molecular Therapeutics
Jan 13, 2025
Maintains: Outperform
Price Target: $31$27
Current: $4.28
Upside: +530.84%
Neurogene
Nov 12, 2024
Maintains: Outperform
Price Target: $45$72
Current: $21.43
Upside: +235.98%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: $17
Current: $1.50
Upside: +1,033.33%
Mirum Pharmaceuticals
Oct 17, 2024
Maintains: Outperform
Price Target: $47$49
Current: $52.66
Upside: -6.95%
BridgeBio Pharma
Oct 17, 2024
Maintains: Outperform
Price Target: $47$46
Current: $46.47
Upside: -1.01%
Wave Life Sciences
Oct 16, 2024
Maintains: Outperform
Price Target: $20$22
Current: $7.70
Upside: +185.71%
Ionis Pharmaceuticals
Jul 24, 2024
Upgrades: Outperform
Price Target: $53$62
Current: $41.73
Upside: +48.57%
Initiates: Outperform
Price Target: $13
Current: $12.71
Upside: +2.28%
Initiates: Outperform
Price Target: $29
Current: $21.01
Upside: +38.03%
Maintains: Outperform
Price Target: $165$230
Current: $18.17
Upside: +1,165.82%
Downgrades: Market Perform
Price Target: $12$4
Current: $5.46
Upside: -26.74%
Upgrades: Outperform
Price Target: n/a
Current: $8.68
Upside: -
Initiates: Outperform
Price Target: $31
Current: $3.31
Upside: +836.56%
Initiates: Outperform
Price Target: $7
Current: $0.68
Upside: +924.59%
Downgrades: Market Perform
Price Target: $40
Current: $18.31
Upside: +118.46%
Downgrades: Underperform
Price Target: $111$93
Current: $33.64
Upside: +176.46%
Maintains: Outperform
Price Target: $86$84
Current: $11.54
Upside: +628.22%
Maintains: Market Perform
Price Target: $6$7
Current: $2.88
Upside: +143.06%
Maintains: Outperform
Price Target: $81$77
Current: $21.16
Upside: +263.89%
Maintains: Market Perform
Price Target: $144$143
Current: $314.94
Upside: -54.59%
Maintains: Market Perform
Price Target: $5$6
Current: $5.74
Upside: +4.53%
Maintains: Outperform
Price Target: $75$76
Current: $56.80
Upside: +33.80%
Maintains: Outperform
Price Target: $30$34
Current: $1.63
Upside: +1,985.89%
Maintains: Market Perform
Price Target: $50$20
Current: $2.54
Upside: +687.40%